Abbott Medical Optics

iOR Partners Welcomes Tom Frinzi to their Board

Retrieved on: 
Wednesday, July 29, 2020
Contact lenses, Abbott Medical Optics, Bausch & Lomb, IOR, Lomb, Cision, Companies, Economy of the United States, Optics

KANSAS CITY, Mo., July 29, 2020 /PRNewswire-PRWeb/ -- iOR Partners, the pioneer in office-based surgery (OBS) in ophthalmology announced that industry veteran, Tom Frinzi, has joined their Board of Directors.

Key Points: 
  • KANSAS CITY, Mo., July 29, 2020 /PRNewswire-PRWeb/ -- iOR Partners, the pioneer in office-based surgery (OBS) in ophthalmology announced that industry veteran, Tom Frinzi, has joined their Board of Directors.
  • He brings 40 years of industry expertise and a sterling reputation as a transformative leader," stated Daniel Durrie, MD., Chairman of the Board of iOR Partners.
  • Frinzi previously served as President of Abbott Medical Optics, President/CEO of WaveTech Vision, Global Commercial Operations at Bausch & Lomb, and CEO of Refractec, Inc.
    "I'm excited to be joining the Board of iOR Partners," said Tom Frinzi.
  • iOR Partners is the only company dedicated to ophthalmic office-based surgery suites and has established more than 100 office-based suites nationwide.

PROCEPT BioRobotics Appoints Reza Zadno, PhD, as New President and CEO

Retrieved on: 
Thursday, February 6, 2020
Surgery, Medical devices, Health, Other Technology, Technology, Articles, Biopunk, Biorobotics, Biotechnology, Cybernetics, Cyberpunk, Fictional technology, Abbott Medical Optics, Fiction, Science fiction

We are exceptionally pleased to appoint Reza to CEO at such a pivotal growth time for PROCEPT BioRobotics.

Key Points: 
  • We are exceptionally pleased to appoint Reza to CEO at such a pivotal growth time for PROCEPT BioRobotics.
  • PROCEPT BioRobotics is a unique company in the robotics space that has the ability to augment surgical technique utilizing next generation robotic technology.
  • Zadno came to PROCEPT BioRobotics after serving as president and CEO of Avedro Inc. (NASDAQ: AVDR), an ophthalmology company that developed a proprietary Corneal Remodeling Platform Technology.
  • Additionally, he was the founder, president and CEO of Visiogen, which was acquired by Abbott Medical Optics (now Johnson & Johnson Vision).

Johnson & Johnson Vision Introduces TECNIS Synergy™ IOL, a Continuous-Range-of-Vision Intraocular Lens (IOL) at the ESCRS 2019 Congress

Retrieved on: 
Monday, September 16, 2019
Medical specialties, Senses, Perception, Corrective lenses, Vision, Ophthalmology, Eye, Intraocular lens, Presbyopia, Johnson & Johnson, Abbott Medical Optics

TECNIS SynergyIOL creates a new standard in presbyopia-correcting intraocular lens (PC-IOL) technology, allowing patients to experience continuous high-contrast vision from far through near, even in low-light conditions1,2.

Key Points: 
  • TECNIS SynergyIOL creates a new standard in presbyopia-correcting intraocular lens (PC-IOL) technology, allowing patients to experience continuous high-contrast vision from far through near, even in low-light conditions1,2.
  • This announcement coincides with the 37th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) in Paris, France, where Johnson & Johnson Vision is also presenting new clinical data on the TECNIS Synergy IOL.
  • trifocal IOLs (PanOptix, FineVision, AT Lisa) in a bench study
    Scientific advisor (paid) to Johnson & Johnson Surgical Vision, Inc.
    *The Johnson & Johnson Medical Devices Companies comprise the surgery, orthopedics, vision and interventional solutions businesses within Johnson & Johnson's Medical Devices segment.
  • TECNIS, TECNIS Synergy, and TECNIS Eyhance are trademarks of Johnson & Johnson Surgical Vision, Inc. All other trademarks are the intellectual property of their respective owners.

Johnson & Johnson Vision Announces Availability in Europe of TECNIS Eyhance IOL, a Next-Generation Monofocal Intraocular Lens for Patients with Cataracts

Retrieved on: 
Monday, February 4, 2019
Senses, Perception, Vision, Ophthalmology, Medical specialties, Eye, Corrective lenses, Intraocular lens, IOL, Johnson & Johnson, Cataract, Abbott Medical Optics

This next-generation monofocal intraocular lens (IOL) allows patients to experience high-quality vision at both intermediate and far distances.

Key Points: 
  • This next-generation monofocal intraocular lens (IOL) allows patients to experience high-quality vision at both intermediate and far distances.
  • "With the availability of TECNIS Eyhance IOL in Europe, we are proud to deliver another meaningful solution for patients with cataracts," said Tom Frinzi, Worldwide President, Surgical, Johnson & Johnson Vision3.
  • TECNIS, TECNIS Eyhance and TECNIS Symfony are trademarks of Johnson & Johnson Surgical Vision, Inc. Johnson & Johnson Surgical Vision, Inc. 2019.
  • 1 TECNIS Eyhance IOL - Product monograph EMEA 2019, table 4.1 SC2019CT4002
    2Johnson & Johnson Surgical Vision, Inc.
    3 Employed by Johnson & Johnson Surgical Vision, Inc.
    4Data on File, Johnson & Johnson Surgical Vision, Inc. 2018.

Johnson & Johnson Vision Launches New Corporate Website

Retrieved on: 
Monday, May 21, 2018
Ophthalmology, Vision, Medicine, Abbott Medical Optics, Eye surgery, Johnson & Johnson, LASIK, Refractive surgery, Cataract, Avi Wallerstein, Jeff Machat

Education: Johnson & Johnson Vision's commitment to professional education and collaboration through the Johnson & Johnson Institute and U.S.

Key Points: 
  • Education: Johnson & Johnson Vision's commitment to professional education and collaboration through the Johnson & Johnson Institute and U.S.
  • In 2017, with the addition of Abbott Medical Optics Inc., the Johnson & Johnson Surgical Vision business, Johnson & Johnson invested further in eye health by expanding into cataract surgery, laser refractive surgery (LASIK) and consumer eye health.
  • Complete information is also available from Johnson & Johnson Vision Care, Inc., by calling 1-800-843-2020, or by visiting www.jnjvisionpro.com .
  • ACUVUE is a trademark of Johnson & Johnson Vision Care, Inc.
    Johnson & Johnson Vision Care, Inc. 2018
    View original content with multimedia: http://www.prnewswire.com/news-releases/johnson--johnson-vision-launches...

Johnson & Johnson Vision Highlights New Data at 2018 Association for Research in Vision and Ophthalmology Annual Meeting

Retrieved on: 
Wednesday, April 25, 2018
Contact lenses, Health, Johnson & Johnson, Acuvue, Arvo, Business, Abbott Medical Optics

JACKSONVILLE, Fla. and SANTA ANA, Calif., April 25, 2018 /PRNewswire/ --Johnson & Johnson Vision, a broad-based global leader in vision, today announced that a suite of new research from its eye health portfolio will be presented at the 2018 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Honolulu, Hawaii from April 29 to May 3.

Key Points: 
  • JACKSONVILLE, Fla. and SANTA ANA, Calif., April 25, 2018 /PRNewswire/ --Johnson & Johnson Vision, a broad-based global leader in vision, today announced that a suite of new research from its eye health portfolio will be presented at the 2018 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Honolulu, Hawaii from April 29 to May 3.
  • Dual headquartered in Jacksonville, Florida, and Santa Ana, California, Johnson & Johnson Vision has more than 10,000 employees worldwide.
  • Complete information is also available from Johnson & Johnson Vision Care, Inc., by calling 1-800-843-2020, or by visiting www.jnjvisionpro.com .
  • TECNIS is a registered trademark of Johnson & Johnson Surgical Vision, Inc.
    ACUVUE is a registered trademark of Johnson & Johnson Vision Care, Inc.
    2018 Johnson & Johnson Vision Care, Inc.